Abstract
We enrolled 91 consecutive inpatients with COVID-19 at 6 hospitals in Toronto, Canada, and tested 1 nasopharyngeal swab/saliva sample pair from each patient using real-time RT-PCR for severe acute respiratory syndrome coronavirus 2. Sensitivity was 89% for nasopharyngeal swabs and 72% for saliva (P = .02). Difference in sensitivity was greatest for sample pairs collected later in illness.
Keywords: COVID-19; SARS-CoV-2; nasopharyngeal swab; saliva.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Saliva, Nasopharyngeal swab, 【초록키워드】 Saliva, coronavirus, hospital, severe acute respiratory syndrome Coronavirus, Nasopharyngeal swab, sensitivity, nasopharyngeal swabs, nasopharyngeal, Patient, real-time RT-PCR, Canada, Inpatient, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, Toronto, difference, enrolled, tested, collected, with COVID-19, 【제목키워드】 detection, coronavirus 2, respiratory,
【저자키워드】 COVID-19, SARS-CoV-2, Saliva, Nasopharyngeal swab, 【초록키워드】 Saliva, coronavirus, hospital, severe acute respiratory syndrome Coronavirus, Nasopharyngeal swab, sensitivity, nasopharyngeal swabs, nasopharyngeal, Patient, real-time RT-PCR, Canada, Inpatient, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, Toronto, difference, enrolled, tested, collected, with COVID-19, 【제목키워드】 detection, coronavirus 2, respiratory,
{{{ 추상적인 }}}
우리는 캐나다 토론토에 있는 6개 병원에 91명의 연속적인 COVID-19 입원 환자를 등록하고 중증 급성 호흡기 증후군 코로나바이러스 2에 대한 실시간 RT-PCR을 사용하여 각 환자의 1개의 비인두 면봉/타액 샘플 쌍을 테스트했습니다. 비인두의 민감도는 89%였습니다. 면봉 및 타액의 경우 72%(P = .02). 민감도의 차이는 나중에 질병에 수집된 샘플 쌍에서 가장 컸습니다.
{{ 키워드: }} 코로나19; 사스 코로나바이러스 2; 비인두 면봉; 타액.